Phase 2 Lung Cancer Trial, Recruiting (NCT04951947)

Phase 2 Lung Cancer Trial, Recruiting NCT04951947 Sponsor: Hunan Province Tumor Hospital Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04951947 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Here is the eligibility information in plain language:

Who might be able to join this trial:

Your cancer has been identified through scans as small cell lung cancer (SCLC) that has spread widely in the body (called "extensive stage")
You have already tried a first-line treatment combining chemotherapy drugs (EC) and an immunotherapy drug (PD-L1 blocker), and that treatment did not work
You are in good general physical health and able to carry out daily activities with little or no limitation (confirm with trial site)

Who may not be able to join:

You have been diagnosed with a different type of lung cancer called non-small cell lung cancer
You are currently pregnant
You have cancer that has spread to the brain and is causing symptoms such as headaches, seizures, or other noticeable problems
Your general physical health and ability to carry out daily activities is significantly limited or worse (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04951947

Sponsor: Hunan Province Tumor Hospital

Phase: Phase 2

Status: Recruiting

Condition: Lung Cancer

More information: https://clinicaltrials.gov/study/NCT04951947

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Here is the eligibility information in plain language:

Who might be able to join this trial:

Your cancer has been identified through scans as small cell lung cancer (SCLC) that has spread widely in the body (called "extensive stage")
You have already tried a first-line treatment combining chemotherapy drugs (EC) and an immunotherapy drug (PD-L1 blocker), and that treatment did not work
You are in good general physical health and able to carry out daily activities with little or no limitation (confirm with trial site)

Who may not be able to join:

You have been diagnosed with a different type of lung cancer called non-small cell lung cancer
You are currently pregnant
You have cancer that has spread to the brain and is causing symptoms such as headaches, seizures, or other noticeable problems
Your general physical health and ability to carry out daily activities is significantly limited or worse (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Hunan Province Tumor Hospital

Registry

ClinicalTrials.gov

Start date

1 June 2023

Est. completion

1 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

ORR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov